Dongguan People's Hospital
Clinical trials sponsored by Dongguan People's Hospital, explained in plain language.
-
Can adding lenvatinib to standard care outsmart a tough brain cancer?
Disease control Not yet recruitingThis phase II trial is asking whether adding the drug lenvatinib to the standard STUPP regimen (temozolomide plus radiation) can improve outcomes for people newly diagnosed with a type of brain cancer called glioblastoma that has a specific genetic marker (MGMT promoter methylati…
Phase: PHASE2 • Sponsor: Dongguan People's Hospital • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Two-Drug combo aims to shrink head and neck tumors before surgery
Disease control Not yet recruitingThis phase 2 trial tests whether adding MRG003 (a targeted drug) to toripalimab (an immunotherapy) before surgery can shrink tumors more than toripalimab alone in people with PD-L1-positive, locally advanced head and neck cancer. Participants receive two cycles of either the comb…
Phase: PHASE2 • Sponsor: Dongguan People's Hospital • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
New drug cocktail aims to boost remission in tough AML cases
Disease control Not yet recruitingThis study tests a new combination of drugs (chidamide, venetoclax, azacitidine, and homoharringtonine) as a first treatment for adults aged 18-60 with intermediate- to high-risk acute myeloid leukemia (AML). The goal is to see if this mix can improve remission rates and reduce t…
Phase: PHASE2 • Sponsor: Dongguan People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC